Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01111396 : Longitudinal Investigation of Hippocampal Function and Morphology in Acute Lymphatic Leukemia (ALL) Patients Treated With Chemotherapy
PhaseN/A
AgesMin: 18 Years Max: 40 Years
Eligibility
Inclusion Criteria:

- Initial diagnosis of acute lymphatic leukaemia (ALL)

- Treatment within the German Multicenter Adult ALL (GMALL 2003) therapy study

- Age 18 to 40 years

- Eligibility for performing study procedure

- Informed consent

Exclusion Criteria:

- Neuropsychiatric disorders

- Present contraindication for MRI investigation (e.g. pacemaker)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01111396      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740